CD-ring modified vitamin D3 analogs and their superagonistic action

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 417-419

  Eelen, Guy ^a   Verlinden, Lieve ^a   Bouillon, Roger ^a   De Clercq, Pierre ^b   Muñoz, Alberto ^c   Verstuyf, Annemieke ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Catenin; CD ring analog; Coactivator; Colon cancer; Non steroidal

Indexed keywords

BETA CATENIN; COLECALCIFEROL DERIVATIVE; FALECALCITRIOL; UVOMORULIN; VITAMIN D RECEPTOR; CADHERIN; CALCITRIOL RECEPTOR; COLECALCIFEROL; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BREAST CANCER; CALCIUM BLOOD LEVEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN MCF 7; COLON CANCER; ONCOGENE C MYC; SYSTEMATIC REVIEW; ANALOGS AND DERIVATIVES; BIOLOGICAL MODEL; CHEMICAL MODEL; COLON TUMOR; DRUG DESIGN; GENE EXPRESSION REGULATION; HUMAN; MEDICINAL CHEMISTRY; METABOLISM; PROCEDURES; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA CATENIN; CADHERINS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CHOLECALCIFEROL; COLONIC NEOPLASMS; DRUG DESIGN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION;

EID: 77954762935     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.01.010     Document Type: Article

References (13)

1. Dusso A.S., Brown A.J., Slatopolsky E. Vitamin D. Am. J. Physiol. Renal. Physiol. 2005, 289(1):F8-28.
2. Deeb K.K., Trump D.L., Johnson C.S. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer 2007, 7(9):684-700.
3. Eelen G., Gysemans C., Verlinden L., Vanoirbeek E., De Clercq P., Van Haver D., Mathieu C., Bouillon R., Verstuyf A. Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Curr. Med. Chem. 2007, 14(17):1893-1910.
4. Verstuyf A., Verlinden L., Van Baelen H., Sabbe K., D'Hallewyn C., De Clercq P., Vandewalle M., Bouillon R. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings. J. Bone Miner. Res. 1998, 13(4):549-558.
5. Verstuyf A., Verlinden L., van Etten E., Shi L., Wu Y., D'Halleweyn C., Van Haver D., Zhu G.D., Chen Y.J., Zhou X., Haussler M.R., De Clercq P., Vandewalle M., Van Baelen H., Mathieu C., Bouillon R. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues. J. Bone Miner. Res. 2000, 15(2):237-252.
6. 3: cis-perhydrindane CE-ring analogues. Bioorg. Med. Chem. Lett. 2004, 14(15):3885-3888.
7. 3: spiro[5,5]undecane CF-ring analogues. Bioorg. Med. Chem. Lett. 2004, 14(15):3889-3892.
8. 3. Tetrahedron Lett. 2009, 50:4174-4177.
9. 3 analogs stabilize helix 12 of the vitamin D receptor. Chem. Biol. 2008, 15(10):1029-1034.
10. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J. Cell Biol. 2001, 154(2):369-387.
11. 3 in target cells. J. Nutr. Sci. Vitaminol (Tokyo) Spec No 1992, 75-78.
12. Schuster I., Egger H., Bikle D., Herzig G., Reddy G.S., Stuetz A., Stuetz P., Vorisek G. Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids 2001, 66(3-5):409-422.
13. Rochel N., Moras D. Ligand binding domain of vitamin D receptors. Curr. Top. Med. Chem. 2006, 6(12):1229-1241.